Karen A. Rossi

2.3k citations

45 papers · 1.3k indexed · h-index 19

Hematology top 2%
- Blood Coagulation and Thrombosis Mechanisms 26
- Hemophilia Treatment and Research 5
Internal Medicine top 5%
Genetics top 5%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 17
Organic Chemistry top 5%
Cardiology and Cardiovascular Medicine top 5%
- Atrial Fibrillation Management and Outcomes 11
Nutrition and Dietetics
- Vitamin K Research Studies 10
Cancer Research
- Protease and Inhibitor Mechanisms 6
Molecular Biology
- Protein Structure and Dynamics 2
- Enzyme function and inhibition 2

Co-authors: Ruth R. Wexler Joseph M. Luettgen Robert M. Knabb Pancras C. Wong Patrick Y. S. Lam Donald Pinto Richard Alexander Angela Smallwood
Cited by: Hematology Internal Medicine Genetics
Journals: Bioorganic & Medicinal Chemistry Letters (24 papers)Journal of Medicinal Chemistry (10 papers)ACS Medicinal Chemistry Letters (2 papers)
Partner nations: United States Germany Sweden

In The Last Decade

Karen A. Rossi

45 papers receiving 1.3k citations

Peers

Countries citing papers authored by Karen A. Rossi

Since Specialization

Citations

This map shows the geographic impact of Karen A. Rossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen A. Rossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen A. Rossi more than expected).

Fields of papers citing papers by Karen A. Rossi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen A. Rossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen A. Rossi. The network helps show where Karen A. Rossi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Karen A. Rossi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Karen A. Rossi Line = papers co-authored together Karen A. Rossi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Rating scales to measure adverse effects of medications in people with intellectual disability: a scoping review European Journal of Clinical Pharmacology ·А.И. Фалин,T Iris,K. Lannon,Emrah Coşkun,محمدجواد شریعت باقری,Giovanny Andrés Sánchez García,Albert Prause,P. Schaubs,Karen A. Rossi,Mingtao Hu	2022	1
2	Discovery of BMS-986318, a Potent Nonbile Acid FXR Agonist for the Treatment of Nonalcoholic Steatohepatitis ACS Medicinal Chemistry Letters ·Joseph Carpenter,Gang Wu,Ying Wang,송주완,Tao Wang,Doree Sitkoff,Karen A. Rossi,Kathy Mosure,Xiaoliang Zhuo,سیدکیوان حسینی,Kristina Sykes,Anthony V. Azzara,豊長原,Matthew G. Soars,Bruce A. Ellsworth,Dean A. Wacker	2021	6
3	Identification of a Hydroxypyrimidinone Compound (21) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure Journal of Medicinal Chemistry ·Wei Meng,Zulan Pi,Olena Koliennikova,Karen A. Rossi,William A. Schumacher,Jeffrey S. Bostwick,Peter S. Gargalovic,Joelle M. Onorato,Liza de Haan,川口由高,Tao Wang,Ruth R. Wexler,Heather J. Finlay	2021	7
4	Orally bioavailable amine-linked macrocyclic inhibitors of factor XIa Bioorganic & Medicinal Chemistry Letters ·Tianan Fang,James R. Corte,Paul J. Gilligan,Yoon Jeon,Vijaya Lakshmi T.,Karen A. Rossi,Joseph E. Myers,S. Sheriff,Zhen Lou,Joanna J. Zheng,Timothy W. Harper,Jeffrey M. Bozarth,Yiming Wu,Joseph M. Luettgen,Dietmar Seiffert,Ruth R. Wexler,Patrick Y. S. Lam	2020	3
5	Pyridazine and pyridazinone derivatives as potent and selective factor XIa inhibitors Bioorganic & Medicinal Chemistry Letters ·Zilun Hu,Christophe Haen,Wei Han,Karen A. Rossi,Jeffrey M. Bozarth,Yiming Wu,S. Sheriff,Joseph E. Myers,Joseph M. Luettgen,Dietmar Seiffert,Ruth R. Wexler,Mimi L. Quan	2018	16
6	Structure-Based Design of Macrocyclic Factor XIa Inhibitors: Discovery of the Macrocyclic Amide Linker Journal of Medicinal Chemistry ·James R. Corte,Tianan Fang,Vijaya Lakshmi T.,Donald Pinto,Karen A. Rossi,Joseph E. Myers,S. Sheriff,Zhen Lou,Joanna J. Zheng,Timothy W. Harper,Jeffrey M. Bozarth,Yiming Wu,Joseph M. Luettgen,Dietmar Seiffert,Carl P. Decicco,Ruth R. Wexler,Mimi L. Quan	2017	29
7	Macrocyclic inhibitors of Factor XIa: Discovery of alkyl-substituted macrocyclic amide linkers with improved potency Bioorganic & Medicinal Chemistry Letters ·James R. Corte,Wu Yang,Tianan Fang,Yufeng Wang,Vijaya Lakshmi T.,Michael James Cressey,William R. Ewing,Karen A. Rossi,Joseph E. Myers,S. Sheriff,Zhen Lou,Joanna J. Zheng,Timothy W. Harper,Jeffrey M. Bozarth,Yiming Wu,Joseph M. Luettgen,Dietmar Seiffert,Mimi L. Quan,Ruth R. Wexler,Patrick Y. S. Lam	2017	12
8	Orally bioavailable pyridine and pyrimidine-based Factor XIa inhibitors: Discovery of the methyl N-phenyl carbamate P2 prime group Bioorganic & Medicinal Chemistry ·James R. Corte,Tianan Fang,Donald Pinto,Michael J. Orwat,Alan R. Rendina,Joseph M. Luettgen,Karen A. Rossi,Anzhi Wei,Vidhyashankar Ramamurthy,Joseph E. Myers,S. Sheriff,Rangaraj Narayanan,Timothy W. Harper,Joanna J. Zheng,Yixin Li,Dietmar Seiffert,Ruth R. Wexler,Mimi L. Quan	2016	15
9	Hemolytic Disease of the Fetus and Newborn due to Intravenous Drug Use American Journal of Perinatology Reports ·Jianfeng Mei,Mona Prasad,Karen A. Rossi,R. O’Shaughnessy,Kara B. Markham	2016	5
10	Structure-based design of inhibitors of coagulation factor XIa with novel P1 moieties Bioorganic & Medicinal Chemistry Letters ·Donald Pinto,Joanne M. Smallheer,James R. Corte,Anne-Laure Negri,Christophe Haen,Tianan Fang,Leon M. Smith,Karen A. Rossi,Alan R. Rendina,Jeffrey M. Bozarth,Ge Zhang,Anzhi Wei,Vidhyashankar Ramamurthy,S. Sheriff,Joseph E. Myers,Paul E. Morin,Joseph M. Luettgen,Dietmar Seiffert,Mimi L. Quan,Ruth R. Wexler	2015	26
11	Orally bioavailable factor Xa inhibitors containing alpha-substituted gem-dimethyl P4 moieties Bioorganic & Medicinal Chemistry Letters ·Michael J. Orwat,Jennifer X. Qiao,Kan He,Alan R. Rendina,Joseph M. Luettgen,Karen A. Rossi,Baomin Xin,Robert M. Knabb,Ruth R. Wexler,Patrick Y. S. Lam,Donald Pinto	2014	7
12	Design and synthesis of bicyclic pyrazinone and pyrimidinone amides as potent TF–FVIIa inhibitors Bioorganic & Medicinal Chemistry Letters ·Xiaojun Zhang,Peter W. Glunz,Wen Jiang,V. S. Ramachandran,Elise Balmand,Frank Barbera,Alvaro Rey Vieites,Alan R. Rendina,Anzhi Wei,T.K. Tan,Karen A. Rossi,Joseph M. Luettgen,Pancras C. Wong,Robert M. Knabb,Ruth R. Wexler,E. Scott Priestley	2013	7
13	Synthesis and SAR of 2,3,3a,4-tetrahydro-1H-pyrrolo[3,4-c]isoquinolin-5(9bH)-ones as 5-HT2C receptor agonists Bioorganic & Medicinal Chemistry Letters ·John M. Fevig,R. Nandakumar,Karen A. Rossi,Keith J. Miller,Ginger Wu,เลิศพร ภาระสกุล,SEDA KURT,X. Li,Ge Zhang,Ma Aránzazu Sánchez García,Mary Jane Cullen,Kenneth W. Rohrbach,一弥西澤,Jinping Gan,Mary Ann Pelleymounter,Jeffrey A. Robl	2012	10
14	Closing the side-chain gap in protein loop modeling Journal of Computer-Aided Molecular Design ·Karen A. Rossi,Akbar Nayeem,Carolyn A. Weigelt,Stanley R. Krystek	2009	2
15	Loopholes and missing links in protein modeling Protein Science ·Karen A. Rossi,Carolyn A. Weigelt,Akbar Nayeem,Stanley R. Krystek	2007	28
16	Preparation of 1-(3-aminobenzo[d]isoxazol-5-yl)-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-ones as potent, selective, and efficacious inhibitors of coagulation factor Xa Bioorganic & Medicinal Chemistry Letters ·Yunlong Li,John M. Fevig,Joseph Cacciola,N.-E. Abriak,Karen A. Rossi,Janan Jona,Robert M. Knabb,Joseph M. Luettgen,Pancras C. Wong,Stephen A. Bai,Ruth R. Wexler,Patrick Y. S. Lam	2006	24
17	SAR and factor IXa crystal structure of a dual inhibitor of factors IXa and Xa Bioorganic & Medicinal Chemistry Letters ·Joanne M. Smallheer,Richard Alexander,Jianmin Wang,Shuaige Wang,K. Wieszorek,Karen A. Rossi,Angela Smallwood,Frank Barbera,Debra Burdick,Joseph M. Luettgen,Robert M. Knabb,Ruth R. Wexler,Prabhakar K. Jadhav	2004	30
18	Nonbenzamidine isoxazoline derivatives as factor Xa inhibitors Bioorganic & Medicinal Chemistry Letters ·Mimi L. Quan,Christopher D. Ellis,Nedorezova Ai,Ann Y. Liauw,Patrick Y. S. Lam,Karen A. Rossi,Robert M. Knabb,Joseph M. Luettgen,Matthew Wright,Pancras C. Wong,Ruth R. Wexler	2003	17
19	The de novo design and synthesis of cyclic urea inhibitors of factor Xa: optimization of the S4 ligand Bioorganic & Medicinal Chemistry Letters ·Robert A. Galemmo,Ananda Rizqi Johansyah,Karen A. Rossi,Richard Alexander,Celia Dominguez,Thomas Maduskuie,Pieter F. W. Stouten,Matthew Wright,Bruce J. Aungst,Pancras C. Wong,Robert M. Knabb,Ruth R. Wexler	2000	10
20	The de novo design and synthesis of cyclic urea inhibitors of factor Xa: Initial sar studies Bioorganic & Medicinal Chemistry Letters ·Robert A. Galemmo,Thomas Maduskuie,Celia Dominguez,Karen A. Rossi,Robert M. Knabb,Ruth R. Wexler,Pieter F. W. Stouten	1998	15

About Karen A. Rossi

Karen A. Rossi is a scholar working on Hematology, Genetics, Nutrition and Dietetics, Cardiology and Cardiovascular Medicine and Cancer Research, having authored 45 papers that have together received 1.3k indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (26 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (17 papers), Atrial Fibrillation Management and Outcomes (11 papers), Vitamin K Research Studies (10 papers), Protease and Inhibitor Mechanisms (6 papers), Hemophilia Treatment and Research (5 papers), Protein Structure and Dynamics (2 papers) and Enzyme function and inhibition (2 papers). The work is most often cited by research in Hematology (416 citations), Internal Medicine (136 citations), Genetics (263 citations), Organic Chemistry (515 citations) and Cardiology and Cardiovascular Medicine (357 citations). Karen A. Rossi has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include Ruth R. Wexler, Joseph M. Luettgen, Robert M. Knabb, Pancras C. Wong, Patrick Y. S. Lam, Donald Pinto, Richard Alexander, Angela Smallwood, Michael J. Orwat and Alan R. Rendina. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters, Journal of Computer-Aided Molecular Design and Bioorganic & Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact